PL1768691T3 - Kompozycje zawierające ekworynę i sposoby ich stosowania - Google Patents

Kompozycje zawierające ekworynę i sposoby ich stosowania

Info

Publication number: PL1768691T3
Authority: PL; Poland
Prior art keywords: aequorin; methods; same; containing compositions; compositions
Prior art date: 2004-06-21

Application number

PL05766584T

Other languages

English (en)

Inventor

Mark Y Underwood

Original Assignee

Quincy Bioscience Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-21

Filing date

2005-06-21

Publication date

2013-09-30

2005-06-21 Application filed by Quincy Bioscience Llc filed Critical Quincy Bioscience Llc

2013-09-30 Publication of PL1768691T3 publication Critical patent/PL1768691T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Toxicology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)

PL05766584T 2004-06-21 2005-06-21 Kompozycje zawierające ekworynę i sposoby ich stosowania PL1768691T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/872,795 US20060229243A1 (en)	2004-06-21	2004-06-21	Aequorin-containing compositions and methods of using same
PCT/US2005/021770 WO2006010004A2 (en)	2004-06-21	2005-06-21	Aequorin-containing compositions and methods of using same
EP05766584.6A EP1768691B1 (en)	2004-06-21	2005-06-21	Aequorin-containing compositions and methods of using same

Publications (1)

Publication Number	Publication Date
PL1768691T3 true PL1768691T3 (pl)	2013-09-30

Family

ID=35785748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05766584T PL1768691T3 (pl)	2004-06-21	2005-06-21	Kompozycje zawierające ekworynę i sposoby ich stosowania

Country Status (21)

Country	Link
US (3)	US20060229243A1 (pl)
EP (2)	EP1768691B1 (pl)
JP (1)	JP4971150B2 (pl)
KR (1)	KR101213555B1 (pl)
CN (1)	CN1997383B (pl)
AU (1)	AU2005265266B2 (pl)
BR (1)	BRPI0512392B1 (pl)
CA (1)	CA2571542C (pl)
CY (1)	CY1114307T1 (pl)
DK (1)	DK1768691T3 (pl)
ES (1)	ES2422173T3 (pl)
HK (1)	HK1109576A1 (pl)
IL (1)	IL180195A (pl)
MX (1)	MXPA06015037A (pl)
NZ (1)	NZ552274A (pl)
PL (1)	PL1768691T3 (pl)
PT (1)	PT1768691E (pl)
SG (1)	SG153848A1 (pl)
SI (1)	SI1768691T1 (pl)
WO (1)	WO2006010004A2 (pl)
ZA (1)	ZA200610688B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060229243A1 (en) *	2004-06-21	2006-10-12	Quincy Resource Group, Inc.	Aequorin-containing compositions and methods of using same
GB0625678D0 (en)	2006-12-21	2007-01-31	Lux Biotechnology Ltd	Composition and method for detection of demineralisation
EP2262525B1 (en) *	2008-03-11	2012-12-26	Quincy Bioscience, LLC	Apoaequorin-containing compositions and methods of using same
JP2010143860A (ja) *	2008-12-19	2010-07-01	Chisso Corp	タンパク質の安定化剤
US20110130336A1 (en) *	2009-10-16	2011-06-02	Quincy Bioscience, Llc	Method of treating ischemic injury using apoaequorin
WO2012086756A1 (ja) *	2010-12-24	2012-06-28	大塚製薬株式会社	生理活性物質を検出するバイオアッセイ法
SI2780027T1 (sl) *	2011-11-15	2017-11-30	Quincy Bioscience Llc	Apoekvorin za zmanjšanje nevronske poškodbe zaradi ishemije
GB201700317D0 (en)	2017-01-09	2017-02-22	Calcivis Ltd	Detection device
USD1042180S1 (en)	2020-05-28	2024-09-17	Calcivis Limited	Dental detection device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001240855A (ja) *	2000-03-01	2001-09-04	Masashi Sugimoto	生物発光方法及び発光物品
US6800492B2 (en) *	2000-06-01	2004-10-05	Institute Pasteur	Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level
WO2001096361A1 (en) *	2000-06-12	2001-12-20	University Of Maryland Biotechnology Institute	Method of controlling the binding of calmyrin to presenilin
US20060229243A1 (en) *	2004-06-21	2006-10-12	Quincy Resource Group, Inc.	Aequorin-containing compositions and methods of using same

2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
2005
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/en active Application Filing
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko active IP Right Grant
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en active Active
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/en active Active
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt active IP Right Grant
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es active Active
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en unknown
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja active Active
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh active Active
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/en not_active Not-in-force
- 2005-06-21 CA CA2571542A patent/CA2571542C/en active Active
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 US US11/571,043 patent/US7671015B2/en active Active
2006
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
2008
- 2008-01-10 HK HK08100338.3A patent/HK1109576A1/xx unknown
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown

Also Published As

Publication number	Publication date
AU2005265266A1 (en)	2006-01-26
EP1768691A2 (en)	2007-04-04
PT1768691E (pt)	2013-06-20
US20080287350A1 (en)	2008-11-20
US20060229243A1 (en)	2006-10-12
WO2006010004A3 (en)	2007-03-08
IL180195A0 (en)	2007-06-03
BRPI0512392B1 (pt)	2022-12-13
KR101213555B1 (ko)	2012-12-18
BRPI0512392A (pt)	2008-03-11
KR20070070154A (ko)	2007-07-03
CN1997383B (zh)	2011-01-05
MXPA06015037A (es)	2007-07-11
CN1997383A (zh)	2007-07-11
US20100152117A1 (en)	2010-06-17
EP2545934B1 (en)	2014-12-10
CY1114307T1 (el)	2016-08-31
IL180195A (en)	2014-03-31
SG153848A1 (en)	2009-07-29
US7671015B2 (en)	2010-03-02
EP2545934A1 (en)	2013-01-16
AU2005265266B2 (en)	2011-05-12
WO2006010004A2 (en)	2006-01-26
ZA200610688B (en)	2007-12-27
EP1768691A4 (en)	2010-08-04
JP4971150B2 (ja)	2012-07-11
DK1768691T3 (da)	2013-07-01
ES2422173T3 (es)	2013-09-09
CA2571542A1 (en)	2006-01-26
CA2571542C (en)	2014-08-19
JP2008503581A (ja)	2008-02-07
HK1109576A1 (en)	2008-06-13
EP1768691B1 (en)	2013-05-22
NZ552274A (en)	2010-06-25
SI1768691T1 (sl)	2013-07-31

Publication	Publication Date	Title
HRP20182133T1 (hr)	2019-03-22	Pripravci koji sadrže azelastin i postupci njihove upotrebe
IL181543A0 (en)	2007-07-04	Dendrimer based compositions and methods of using the same
ZA200802490B (en)	2009-10-28	Isoindole-imide compounds and compositions comprising and methods of using the same
IL180907A0 (en)	2007-07-04	Risedronate compositions and their methods of use
IL213843A0 (en)	2011-07-31	4-aminotetracyclines and methods of use thereof
IL219406A0 (en)	2012-06-28	Antiloading compositions and methods of selecting same
IL182943A0 (en)	2007-09-20	Ovr110 antibody compositions and methods of use
ZA200606545B (en)	2008-02-27	Chronotherapeutic compositions and methods of their use
HK1109576A1 (en)	2008-06-13	Aequorin-containing compositions and methods of using same
IL184062A0 (en)	2007-10-31	Visco-supplement composition and methods
EP1786265A4 (en)	2009-08-19	NEW COMPOSITIONS AND PROCESSING METHODS
EP1778219A4 (en)	2010-06-30	ASCOPHYLUM COMPOSITIONS AND METHODS
IL179962A0 (en)	2007-05-15	Compositions and methods of use of dimer digallates
EP1765321A4 (en)	2008-10-01	ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE THEREOF
GB0520930D0 (en)	2005-11-23	Composition and method of use
ZA200706038B (en)	2008-12-31	Visco-supplement composition and methods
GB0504657D0 (en)	2005-04-13	Compositions and methods of treatment
GB0428034D0 (en)	2005-01-26	Compositions and methods
GB0517168D0 (en)	2005-09-28	Composition and method of use
AU2005904981A0 (en)	2005-09-22	Compositions and methods of using same
AU2005904711A0 (en)	2005-09-15	Compositions and methods of use thereof
GB0419260D0 (en)	2004-09-29	Skincare compositions and methods
AU2004900511A0 (en)	2004-02-19	Compositions and Methods of Treatment
AU2004904405A0 (en)	2004-08-26	Compositions and Methods of Treatment